Swanson Luke Roy Files to Sell 8,764 Shares of Ibotta, Inc.
Swanson Luke Roy has filed to sell 8,764 shares of Ibotta, reflecting ongoing insider activity in the advertising services sector.
UBS AG files preliminary pricing supplement for new Notes
UBS AG announces a new offering of Trigger Autocallable Contingent Yield Notes linked to AMD, highlighting innovative financial products in banking.
VISA Foundation reports $153.7 million in latest 13F-HR
VISA Foundation reveals $153.7 million in holdings in its recent 13F-HR filing. The report reflects its investment strategy as of September 30, 2026.
Wells Fargo Finance LLC Files Preliminary Pricing Supplement
Wells Fargo Finance LLC files a preliminary pricing supplement for Medium-Term Notes, highlighting its strategy in the competitive banking sector.
UBS AG Launches $200 Million Autocallable Yield Notes
UBS AG announces a $200 million offering of Trigger Autocallable Contingent Yield Notes linked to Meta Platforms, Inc., marking a strategic move in the banking sector.
Microsoft announces 2026 annual shareholders meeting details
Microsoft Corp. reveals details for its 2026 annual shareholders meeting, highlighting governance changes and encouraging shareholder participation.
Shapira Matteo Updates Ownership Report for Xtend AI Robotics
Shapira Matteo corrects his ownership report for Xtend AI Robotics, reflecting a commitment to transparency in the tech industry.
Smith Shellnut Wilson reports $262M in Q3 2026 holdings
Smith Shellnut Wilson LLC /ADV disclosed its Q3 2026 holdings totaling over $262 million, showcasing its investment strategy and market positioning.
Vivos Therapeutics files preliminary proxy statement for changes
Vivos Therapeutics, Inc. has filed a preliminary proxy statement, signaling upcoming changes that could impact its strategy in the medical instruments industry.
JPMorgan Chase Financial Co. LLC Unveils New Securities
JPMorgan Chase Financial Co. LLC has filed for new structured investment securities linked to Micron Technology, signaling innovation in the banking sector.
20/20 Biolabs to Hold Special Meeting on Reverse Stock Split
20/20 Biolabs, Inc. will hold a Special Meeting on December 9, 2026, to discuss a proposed reverse stock split and other business matters.
iShares Trust reports $21.82 billion in assets in NPORT-P
iShares Trust reveals $21.82 billion in assets in latest NPORT-P filing, emphasizing transparency and strong holdings in U.S. Treasury securities.
AFG Fiduciary Services reveals $131.1M in Q3 holdings
AFG Fiduciary Services files 13F-HR, reporting $131.1 million in holdings as of September 30, 2026, reflecting its investment strategies and market positions.
Citigroup raises €2.75 billion through debt issuance
Citigroup announces €2.75 billion debt issuance through fixed and floating rate notes, signaling financial strategy and industry impact.
Shinhan Financial Group Amends Share Cancellation Filing
Shinhan Financial Group updates share cancellation details in new filing, reflecting its recent share repurchase program completion.
Harbor Capital Advisors discloses $1.48M in holdings report
Harbor Capital Advisors, Inc. reports $1.48 million in holdings as of September 30, 2026, reflecting its investment strategies in the financial services sector.
Trellis Bioscience files new offering to raise capital
Trellis Bioscience, Inc. files a new offering under Rule 506(b) to secure funding through equity and convertible notes, enhancing its capital position.
Trellis Bioscience files new private offering under Rule 506(b)
Trellis Bioscience, Inc. has filed a new offering under Rule 506(b), reflecting a trend in the biotech sector for alternative funding methods.
Advisors Disciplined Trust 2364 Certifies Registration Update
Advisors Disciplined Trust 2364 confirms its registration statement compliance with the SEC, ensuring consistency in its fund operations.
iShares Trust Reports Financials in Latest NPORT-P Filing
iShares Trust's recent NPORT-P filing reveals significant assets and liabilities, showcasing its position in the investment sector.